Picture of Rhoen Klinikum AG logo

RHK Rhoen Klinikum AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

German stocks - Factors to watch on August 2

BERLIN, Aug 2 (Reuters) - The following are some of the
factors that may move German stocks on Thursday:
    
    BMW  BMWG.DE  
    Q2 results due. EBIT seen down 8 percent at 2.69 billion
euros ($3.13 billion). Poll:  urn:newsml:reuters.com:*:nL5N1UN3QL
    BMW brand U.S. sales rose 0.1 percent in July to 21,982
vehicles.  urn:newsml:reuters.com:*:nFWN1US0YV
    
    CONTINENTAL  CONG.DE  
    Q2 results due. Adjusted EBIT seen up 2.5 percent at 1.2
billion euros. Poll:  urn:newsml:reuters.com:*:nL5N1UN538
    
    DAIMLER  DAIGn.DE 
    Mercedes-Benz U.S. sales plunged 23 percent in July to
20,034 cars.  urn:newsml:reuters.com:*:nFWN1US0YY
    
    PROSIEBENSAT.1  PSMGn.DE  
    Q2 results due. Core profit seen down 5 percent at 256
million euros. Poll:  urn:newsml:reuters.com:*:nL5N1UR6SE
    
    SIEMENS  SIEGn.DE  
    The engineering group unveiled its new Vision 2020+ strategy
on Wednesday - a move designed to boost profitability in an era
where sprawling conglomerates are increasingly unloved by
investors.  urn:newsml:reuters.com:*:nL5N1US78P
    Q3 results due. Industrial business profit seen stable at
able 2.17 billion euros. Poll:  urn:newsml:reuters.com:*:nL5N1UQ4CA
    Siemens has bought U.S.-based IT firm Mendix for 600 million
euros to strengthen its software operations.  urn:newsml:reuters.com:*:nFWN1US12B
    
    VOLKSWAGEN  VOWG_p.DE  
    Q2 results due from VW brand. The VW group already published
key figures for the brand on Wednesday.

    EVONIK  EVKn.DE  
    Full Q2 results due. The group published key figures on July
17 and raised its core profit guidance.  urn:newsml:reuters.com:*:nASM000M3A
    
    HUGO BOSS  BOSSn.DE  
    Q2 results due. Net profit seen down 8 percent at 52.8
million euros. Poll:  urn:newsml:reuters.com:*:nL5N1UR6O2
    
    LANXESS  LXSG.DE  
    Q2 results due. Adjusted EBITDA seen up 2.9 percent at 288
million euros. Poll:  urn:newsml:reuters.com:*:nL5N1UR6FO
    
    METRO  B4B.DE  
    Q3 results due. EBIT seen down 38 percent at 133 million
euros. Poll:  urn:newsml:reuters.com:*:nL5N1UR6NO
    
    RHEINMETALL  RHMG.DE  
    Q2 results due. Net income seen up 20 percent at 268 million
euros. Poll:  urn:newsml:reuters.com:*:nL5N1UR4VW

    DIALOG SEMICONDUCTOR  DLGS.DE  
    Full Q2 results due. The group published preliminary results
on July 13.  urn:newsml:reuters.com:*:nFWN1U90HA
    
    MORPHOSYS  MORG.DE 
    The biotech firm reported lower second-quarter sales and a
greater operating loss but reaffirmed its improved financial
guidance for 2018.  urn:newsml:reuters.com:*:nASO00069G
    
    PFEIFFER VACUUM  PV.DE  
    Q2 results due. Operating profit seen up 67 percent at 24.4
million euros. Poll:  urn:newsml:reuters.com:*:nL5N1UQ4U0

    DELIVERY HERO  DHER.DE  
    Q2 results due.
    
    BIOTEST  BIOG.DE 
    The company said it has completed a sale of all of its
U.S.-based plasma collection centres for $286 million.
 urn:newsml:reuters.com:*:nASO00069A
    
    DEUTZ  DEZG.DE  
    Q2 results due. The group raised its full-year guidance on
July 27. Poll:  urn:newsml:reuters.com:*:nASM000MFY
    
    RHOEN-KLINIKUM  RHKG.DE  
    Q2 results due.
            
    ANALYSTS' VIEWS
    FMC  FMEG.DE  - CFRA cuts to "hold" from "buy", cuts price
target to 90 euros from 93 euros.
                
    OVERSEAS STOCK MARKETS  
    Dow Jones  .DJI  -0.3 pct, S&P 500 .SPX  -0.1 pct, Nasdaq
 .IXIC  +0.5 pct at close.  .N 
    Nikkei  .N225  -1.1 pct, Shanghai stocks  .SSEC  -2.5 pct.
    Time: 4.43 GMT.  .T   .SS 
    
    GERMAN ECONOMIC DATA
    No economic data scheduled.
    
    EUROPEAN FACTORS TO WATCH  WATCH/EU 
    DIARIES  DE/DIA   WEU/EQUITY 
    REUTERS TOP NEWS  TOP/NEWS 

($1 = 0.8586 euros)

 (Reporting by Andreas Cremer and Maria Sheahan)
 ((maria.sheahan@thomsonreuters.com; +49 69 7565 1286; Reuters
Messaging: maria.sheahan.thomsonreuters.com@reuters.net))

Recent news on Rhoen Klinikum AG

See all news